IL2 and neoplasm: PEGylated liposomes functionalized with interleukin-2 (IL-2) and anti-CD137, immunostimulatory agents that activate CTLs and NK cells, accumulated quickly towards the tumor, improved immune cell infiltration, and stimulated cytokine production [16].